Showing results (31-40 of 153) with videos related to
Sort By:
Pageof 16
Current Medicinal Chemistry|July 29, 2004
Clinical applications of MAO-inhibitorsP Riederer, L Lachenmayer, G LauxDer Nervenarzt|June 8, 2014
[Principles of evaluating driving ability for neurological and psychiatric diseases]A Brunnauer, B Widder, G LauxJournal of Neural Transmission. Supplementum|November 7, 2007
Therapeutic drug monitoring of antidepressants--clinical aspectsG Laux, P Baumann, C Hiemke, et al.Psychiatrische Praxis|August 1, 1989
[Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants]T Becker, M Struck, G LauxPharmacopsychiatry|March 1, 1988
Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics--a study comparing adjuvant treatment with oxazolam versus chlorprothixeneG Laux, W Koenig, G PfaffNeuropsychobiology|January 1, 1988
Psychotropic effects of corticotropin-releasing hormone stimulation in depressive patientsG Laux, K P Lesch, M SchwabPharmacopsychiatry|June 1, 2012
Treatment of comorbid anxiety and depression with escitalopram: results of a post-marketing surveillance studyG Laux, M Friede, W E MüllerThe EMBO Journal|March 1, 1988
A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genomeG Laux, M Perricaudet, P J FarrellThe Journal of General Virology|November 1, 1989
The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter regionG Laux, A Economou, P J FarrellPageof 16